{"disease":{"id":"chronic-cough","name":"chronic cough"},"drugs":{"marketed":[{"drug_id":"gefapixant-citrate","indication_name":"Refractory chronic cough","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lyfnua","generic_name":"GEFAPIXANT CITRATE","company_name":"Msd K.K.","drug_phase":"marketed","molecular_target":"P2X purinoceptor 3","drug_class":"","quality_score":17,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06862362","title":"China Chronic Cough Registry: a Multicenter, Prospective, Observational Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":6000,"lead_sponsor_name":"The First Affiliated Hospital of Guangzhou Medical University","has_results":false},{"nct_id":"NCT03449147","title":"A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1317,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05600777","title":"A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":975,"lead_sponsor_name":"Bellus Health Inc. - a GSK company","has_results":false},{"nct_id":"NCT05599191","title":"A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":825,"lead_sponsor_name":"Bellus Health Inc. - a GSK company","has_results":false},{"nct_id":"NCT03449134","title":"A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":732,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04393909","title":"Improving Safety of Diagnosis and Therapy in the Inpatient Setting","phase":"NA","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT06503939","title":"Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":600,"lead_sponsor_name":"Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT04694963","title":"A Multi-center Study to Determine the Prevalence and Influence of Pertussis on Subacute Cough in Shenzhen","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Shenzhen People's Hospital","has_results":false},{"nct_id":"NCT06504446","title":"Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":455,"lead_sponsor_name":"Nocion Therapeutics","has_results":false},{"nct_id":"NCT04193202","title":"Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":419,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04110054","title":"Evaluation of S-600918 in Adults With Refractory Chronic Cough","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":406,"lead_sponsor_name":"Shionogi","has_results":true},{"nct_id":"NCT04193176","title":"Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":376,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT02993822","title":"A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":315,"lead_sponsor_name":"Nerre Therapeutics Ltd.","has_results":true},{"nct_id":"NCT04562155","title":"Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":310,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT04678206","title":"Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":310,"lead_sponsor_name":"Bellus Health Inc. - a GSK company","has_results":false},{"nct_id":"NCT02612610","title":"A 12-Week Study in Participants With Refractory Chronic Cough (MK-7264-012)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":253,"lead_sponsor_name":"Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT07190664","title":"A Prospective, Randomized, Double-blind Study on the Effects of Different Anesthesia Strategies on Postoperative Cough in Patients Undergoing Video-assisted Thoracoscopic Surgery.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":228,"lead_sponsor_name":"Fujian Medical University Union Hospital","has_results":false},{"nct_id":"NCT03282591","title":"Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":185,"lead_sponsor_name":"Vyne Therapeutics Inc.","has_results":true},{"nct_id":"NCT05362097","title":"Analysis of the Reliability and Validity of the Chinese Version of CC-QoL","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Guangzhou Institute of Respiratory Disease","has_results":false},{"nct_id":"NCT07483489","title":"A Phase 2 Study of HW091077 in Participants With Refractory Chronic Cough Or Unexplained Chronic Cough (RCC/UCC).","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.","has_results":false},{"nct_id":"NCT04882943","title":"COllaboration REsearch on Chronic Cough (COREC): a French Multicenter Database","phase":"","overall_status":"TERMINATED","enrollment_count":178,"lead_sponsor_name":"University Hospital, Toulouse","has_results":false},{"nct_id":"NCT03696108","title":"A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04525885","title":"A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China Extension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":161,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05642559","title":"Study for the Development and Validation of Chronic Cough Patient Perspective Questionnaire","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Ospedale Policlinico San Martino","has_results":false},{"nct_id":"NCT06960759","title":"Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":135,"lead_sponsor_name":"University of Montana","has_results":false},{"nct_id":"NCT05265871","title":"ATP Level and Cough Sensitivity to ATP in Subjects With Refractory/Unexplained Chronic Cough","phase":"","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Kefang Lai","has_results":true},{"nct_id":"NCT07288528","title":"A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":124,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT04247997","title":"Effect of Disconnecting Pulmonary Vagus Nerve Branch on Chronic Cough After Unilateral Thoracoscopic Lobectomy","phase":"NA","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"Han Yuan","has_results":false},{"nct_id":"NCT04866563","title":"A Study of Efficacy and Safety of AX-8 in Chronic Cough","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Axalbion SA","has_results":false},{"nct_id":"NCT03864328","title":"A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":108,"lead_sponsor_name":"Respivant Sciences GmbH","has_results":false},{"nct_id":"NCT05522699","title":"Cough Suppressive Therapy in Patients With Chronic Cough","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT04758351","title":"Prospective Study on the Evaluation, Patient Reported Outcomes and Effectiveness of Treatment for Chronic Cough","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT05733533","title":"A Study to Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic Cough","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Guangdong Hengrui Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT05274516","title":"A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Guangdong Hengrui Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT03662269","title":"Indomethacin for Refractory Chronic Cough","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":84,"lead_sponsor_name":"The First Affiliated Hospital of Guangzhou Medical University","has_results":false},{"nct_id":"NCT03979638","title":"A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":68,"lead_sponsor_name":"Bellus Health Inc. - a GSK company","has_results":true},{"nct_id":"NCT05962151","title":"Refractory Chronic Cough Improvement Via NAL ER (RIVER)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Trevi Therapeutics","has_results":true},{"nct_id":"NCT06542484","title":"The Real-world Treatment Satisfaction by Gefapixiant in RCC","phase":"NA","overall_status":"RECRUITING","enrollment_count":63,"lead_sponsor_name":"Nagoya City University","has_results":false},{"nct_id":"NCT03639727","title":"Cough in Eastern and Central Finland","phase":"NA","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Kuopio University Hospital","has_results":false},{"nct_id":"NCT06376448","title":"An Observational Study Using Novel Questionnaire to Characterize Cough Phenotypes in Patients With Chronic Cough","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Hull University Teaching Hospitals NHS Trust","has_results":false},{"nct_id":"NCT06706765","title":"Group Telehealth Behavioral Cough Suppression Therapy","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Montana","has_results":false},{"nct_id":"NCT06782893","title":"Chronic COUGH Management in Interstitial Lung DisEase","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Aveiro University","has_results":false},{"nct_id":"NCT02349425","title":"A Dose Escalation Study of Gefapixant (AF-219/MK-7264) in Refractory Chronic Cough (MK-7264-010)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT05392192","title":"A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Aldeyra Therapeutics, Inc.","has_results":true},{"nct_id":"NCT05689307","title":"Validation Study With a Non-CE Marked Medical Device (MD)","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Siva Health AG","has_results":false},{"nct_id":"NCT02397460","title":"Effect of Gefapixant (AF-219/MK-7264) on Cough Reflex Sensitivity (MK-7264-015)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT05660850","title":"A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Genentech, Inc.","has_results":true},{"nct_id":"NCT03622216","title":"A Dose Escalation Study of Bradanicline in Refractory Chronic Cough","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Attenua, Inc.","has_results":false},{"nct_id":"NCT04765722","title":"Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"McMaster University","has_results":true},{"nct_id":"NCT06634823","title":"Efficacy of Intramuscular Steroid Injection for Chronic Cough.","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Medical University of South Carolina","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}